Correction of PTEN mutations in glioblastoma cell lines via AAV-mediated gene editing

Victoria K. Hill, Jung Sik Kim, C. David James, Todd Waldman

Research output: Contribution to journalArticlepeer-review

12 Scopus citations


PTEN is among the most commonly mutated tumor suppressor genes in human cancer. However, studying the role of PTEN in the pathogenesis of cancer has been limited, in part, by the paucity of human cell-based isogenic systems that faithfully model PTEN loss. In an effort to remedy this problem, gene editing was used to correct an endogenous mutant allele of PTEN in two human glioblastoma multiforme (GBM) cell lines- 42MGBA and T98G. PTEN correction resulted in reduced cellular proliferation that was Akt-dependent in 42MGBA cells and Akt-independent in T98G cells. This is the first report of human cancer cell lines in which mutant PTEN has been corrected by gene editing. The isogenic sets of gene edited cell lines reported here will likely prove useful for further study of PTEN mutations in the pathogenesis of cancer, and for the discovery and validation of novel therapeutics targeting the PTEN pathway.

Original languageEnglish (US)
Article numbere0176683
JournalPloS one
Issue number5
StatePublished - May 2017

ASJC Scopus subject areas

  • General


Dive into the research topics of 'Correction of PTEN mutations in glioblastoma cell lines via AAV-mediated gene editing'. Together they form a unique fingerprint.

Cite this